Umeå University study finds mix-and-match of Covid-19 vaccines reduces risk
People who received the first dose of AstraZeneca’s shot and the second dose of Pfizer-BioNTech’s vaccine had a 67% low…
Sweden
Latest in
Sweden
Denmark and Sweden pause use of Moderna’s Spikevax for younger people
Recent data points to an increased risk of myocarditis and pericarditis among younger age groups who receive Spikevax.
Advent and GIC offer to acquire biopharma company Sobi for $8bn
Sobi has more than ten late-stage R&D programmes that are intended for areas with unmet medical needs.
Ipsen and IRLAB sign $363m deal for Parkinson’s disease therapy
Mesdopetam is presently being assessed in Phase IIb trials for treating Parkinson’s patients experiencing involuntary movements.
ISR and Iconovo agree to develop inhaled Covid-19 vaccine
Immune System Regulation (ISR) has entered an agreement to develop an inhaled Covid-19 vaccine in Iconovo's ICOone inhaler.
BioInvent signs monoclonal antibody manufacturing deal with Cantargia
Clinical stage firm BioInvent International and Cantargia have signed a manufacturing agreement for monoclonal antibody CAN10 to treat systemic sclerosis…
Apellis enters drug development and commercialisation deal with Sobi
Apellis Pharmaceuticals has entered into a strategic collaboration with Swedish Orphan Biovitrum (Sobi) to fast-track the advancement of systemic pegcetacoplan…
Eir Ventures launches to unlock the potential of the Nordics
Supported by three prestigious investment companies and the EU's EIF, Eir Ventures is a Nordic-based venture company with €76m to…
By